saw palmetto berry and Reduced Total Prostate-Specific Antigen Level

Doses used in studies

mg/day: 160 (median 160, IQR 160–160) — 1 study

Time to effect

Median: 12.2 months · IQR 12.2 months–12.2 months · Range 12.2 months–12.2 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityNo significant difference
The incidence of side effects was similar in the two groups.
from: Saw palmetto for benign prostatic hyperplasia.

1 of 1 paper

Saw palmetto for benign prostatic hyperplasia.

2006-02-09
RCT · n = 225
The New England journal of medicine 354(6)
- Stephen Bent
- Christopher Kane
- Katsuto Shinohara
- John Neuhaus
- Esther S Hudes
- Harley Goldberg
- Andrew L Avins

PubMed: 16467543
DOI: 10.1056/nejmoa053085

6 Insights on

Reduced Total Prostate-Specific Antigen Level

High evidence
Large Human Trial
Highly Cited
Clinical

There was no significant difference between the saw palmetto and placebo groups in the change in ... serum prostate-specific antigen levels during the one-year study.

Effect: Neutral
Effect size: Small
Significant: No
Dose: 160 mg twice a day